Skip to content
Review

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

2026 · [Rinsho ketsueki] The Japanese journal of clinical hematology · Vol 67 8, pp. 992-997 · 0 citations
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.